Anfield Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Anfield Capital Management's DXCM Position: Q1 2026 in Review
Anfield Capital Management increased its DexCom (DXCM) stake by 33% in Q1 2026, buying an estimated $27.9K and bringing the position to 1,600 shares worth $100K. The position accounts for 0.03% of the portfolio, ranked #180.
Anfield Capital Management first reported a position in DXCM in Q1 2024 and has held it in 9 quarters since. The position peaked at $136K in Q2 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Anfield Capital Management held 1,600 shares of DexCom worth $100K as of Q1 2026.
- Anfield Capital Management bought 400 DexCom shares in Q1 2026, an estimated $27.9K.
- DexCom made up 0.03% of Anfield Capital Management's portfolio in Q1 2026, its #180 holding.
- Anfield Capital Management first reported a position in DexCom in Q1 2024 and has held it in 9 quarters since.
- Anfield Capital Management's DexCom position peaked at $136K in Q2 2024.
- 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.